{
  "symbol": "LLY",
  "name": "Lilly (Eli)",
  "sector": "Health Care",
  "industry": "Pharmaceuticals",
  "date_added": "1970-12-31",
  "headquarters": "Indianapolis, Indiana",
  "founded": "1876",
  "market_cap": 705710.260224,
  "pe_ratio": 63.96257,
  "forward_pe": 34.691086,
  "eps": 12.29,
  "revenue": 49003.200512,
  "profit_margin": 0.22665001,
  "debt_to_equity": 243.609,
  "return_on_equity": 0.77278,
  "dividend_yield": 0.77,
  "current_price": 786.0999755859375,
  "year_high": 967.2688399516576,
  "year_low": 675.7049652264799,
  "price_change_1d": 1.0853075550845719,
  "price_change_1w": 1.3145960627566304,
  "price_change_1m": 2.666908252205418,
  "description": "Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic ",
  "website": "https://www.lilly.com",
  "employees": 47000,
  "exchange": "NYQ",
  "currency": "USD",
  "analyst_target_price": 951.9752,
  "recommendation": 1.72414,
  "number_of_analysts": 27,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 1190.0,
    "target_low": 650.0,
    "target_mean": 951.9752,
    "target_median": 970.0
  },
  "last_updated": "2025-07-09T11:24:49.461412",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}